Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Presence of particulate matter: identified as Buprenorphine free base
Quick Facts at a Glance
- Recall Date
- March 13, 2026
- Hazard Level
- HIGH
- Brands
- BUPRENORPHINE HYDROCHLORIDE, Par Health USA, LLC
- Geographic Scope
- 1 states
Hazard Information
Presence of particulate matter: identified as Buprenorphine free base
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact ENDO USA, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for BUPRENORPHINE HYDROCHLORIDE recalls
Be the first to know. Free instant alerts to your inbox.
Full Description
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.. Generic: BUPRENORPHINE HYDROCHLORIDE; Brand: BUPRENORPHINE HYDROCHLORIDE. Reason: Presence of particulate matter: identified as Buprenorphine free base. Classification: Class II. Quantity: 34,293 vials. Distribution: USA Nationwide
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsWant to Know First?
Get instant alerts for recalls that affect you. Free forever.